LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
83 hedge funds and large institutions have $718M invested in La Jolla Pharmaceutical Company in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 46 increasing their positions, 15 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
14% less funds holding
Funds holding: 96 → 83 (-13)
40% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 25
Holders
83
Holding in Top 10
5
Calls
$11.7M
Puts
$5.28M
Top Buyers
| 1 | +$25.2M | |
| 2 | +$24.7M | |
| 3 | +$17.6M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$15.2M |
| 5 |
BC
Broadfin Capital
New York
|
+$14.1M |
Top Sellers
| 1 | -$24.3M | |
| 2 | -$8.01M | |
| 3 | -$7.69M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.3M |
| 5 |
CLCM
Crawford Lake Capital Management
Lakewood,
New Jersey
|
-$5.12M |